(Q44094081)

English

Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacte

scientific article published on May 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacte (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Inhibitory and Bactericidal activity of selected β-lactam agents alone and in combination with β-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group (English)

reason for preferred rank

most precise value

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611847

15 October 2022

1 reference

based on heuristic

inferred from title

author name string

C. W. Stratton

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611847

15 October 2022

L. S. Weeks

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611847

15 October 2022

K. E. Aldridge

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1611847

15 October 2022

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 1992

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:073288939290018O?httpAccept=text/xml

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

https://api.elsevier.com/content/article/PII:073288939290018O?httpAccept=text/plain

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

321-330

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production.

1

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.

2

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology

4

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Comparative activity of beta-lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with beta-lactams against beta-lactamase-producing anaerobes

5

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

In-vitro susceptibility of the Bacteroides fragilis group to cefoperazone, ampicillin, ticarcillin and amoxycillin combined with beta-lactamase inhibitors.

6

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid

7

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents

8

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo

9

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.

10

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

The in-vitro susceptibility of the Bacteroides fragilis group to amoxycillin-clavulanic acid

11

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance

12

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

13

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis

14

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Permeability to beta-lactams in Bacteroides fragilis

15

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Cefoxitin inactivation by Bacteroides fragilis

16

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group

17

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

In vitro activity of cefoperazone/sulbactam and other antimicrobials against anaerobic bacteria

18

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic

19

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis

20

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Characterization of beta-lactamases in clinical isolates of Bacteroides

21

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Susceptibility testing of anaerobic bacteria

22

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

In vitro comparison of cefoperazone/sulbactam with selected antimicrobials against 300 bacteroides isolates. Inhibitory activity and time-kill kinetic studies.

24

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.

25

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Isolation of beta-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections

26

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase

27

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres

28

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Bacteroides fragilis resistant to both metronidazole and imipenem.

29

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam

30

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Factors Contributing to Resistance to Beta-Lactam Antibiotics in Bacteroides fragilis

33

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibility

34

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Properties of the penicillin-binding proteins of four species of the genus Bacteroides.

35

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients

36

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

The beta-lactamases of genus Bacteroides

38

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Inactivation of Cephalosporins by Bacteroides

39

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Nationwide study of the susceptibility of the Bacteroides fragilis group in the United States

40

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

The beta-lactamases of Bacteroides species

41

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Comparative in vitro activities of a new quinolone, WIN 57273, and piperacillin plus tazobactam against anaerobic bacteria

42

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Antimicrobial resistance in Bacteroides

43

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria

44

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

The penetration of amoxycillin/clavulanic acid into peritoneal fluid

45

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Properties of novel beta-lactamase produced by Bacteroides fragilis

46

1 reference

10.1016/0732-8893(92)90018-O

https://api.crossref.org/works/10.1016/0732-8893(92)90018-O

15 October 2022

Identifiers

10.1016/0732-8893(92)90018-O

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44094081&oldid=1768057336"